Weily Soong Selected Research

Urticaria (Hives)

11/2022

Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weily Soong Research Topics

Disease

15	Atopic Dermatitis (Atopic Eczema) 01/2023 - 01/2016
9	Asthma (Bronchial Asthma) 02/2024 - 03/2016
5	Eczema 01/2023 - 01/2022
3	Chronic Urticaria 12/2023 - 01/2022
2	Pruritus (Itching) 01/2023 - 01/2022
2	Conjunctivitis 01/2023 - 01/2022
2	Hypersensitivity (Allergy) 01/2021 - 07/2019
2	Nasopharyngitis 01/2021 - 01/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 01/2016
1	Inflammation (Inflammations) 01/2023
1	Urticaria (Hives) 11/2022
1	Angioedema 11/2022
1	Body Weight (Weight, Body) 05/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Headache (Headaches) 01/2021
1	Acne Vulgaris 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Bacterial Infections (Bacterial Infection) 07/2019

Drug/Important Bio-Agent (IBA)

9	dupilumabIBA 01/2023 - 01/2016
7	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022 - 03/2016
4	Monoclonal AntibodiesIBA 02/2024 - 01/2016
3	Interleukin-13IBA 02/2024 - 01/2016
3	upadacitinibIBA 01/2023 - 01/2021
3	abrocitinibIBA 01/2023 - 01/2022
3	Immunoglobulin A (IgA)IBA 01/2023 - 01/2022
3	Immunoglobulin E (IgE)IBA 01/2022 - 03/2016
3	AllergensIBA 01/2021 - 03/2016
2	tralokinumabIBA 01/2023 - 11/2022
2	Interleukin-4 (Interleukin 4)IBA 01/2023 - 01/2016
2	Interleukin-33IBA 12/2022 - 01/2021
2	astegolimabIBA 12/2022 - 01/2021
2	ligelizumabIBA 11/2022 - 01/2022
2	Omalizumab (Xolair)FDA Link 11/2022 - 01/2021
1	lebrikizumabIBA 02/2024
1	Histamine Antagonists (Antihistamines)IBA 12/2023
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	AlarminsIBA 01/2021
1	Janus KinasesIBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Amoxicillin (Wymox)FDA LinkGeneric 07/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2019
1	Penicillins (Penicillin)FDA Link 07/2019
1	InterleukinsIBA 01/2016
1	Bronchodilator Agents (Bronchodilators)IBA 01/2016
1	aclidinium bromideIBA 01/2016
1	Formoterol Fumarate (Oxis)FDA Link 01/2016

Therapy/Procedure

10	Therapeutics 12/2023 - 03/2016
3	Biological Therapy 11/2023 - 01/2020
1	Length of Stay 07/2019
1	Aftercare (After-Treatment) 01/2016